Depression Updates and Selective Serotonin Reuptake Inhibitor Management

Area of Science:

• Primary Care Medicine
• Psychiatry
• Adolescent Health

Background:

• Depression is a growing public health concern, particularly in primary care settings and among adolescents.
• Routine screening for depression is supported by evidence, showing benefits in remission and symptom reduction for adults and perinatal populations.

Purpose of the Study:

• To review the evidence supporting depression screening in primary care.
• To discuss effective first-line treatments for depression, including psychotherapy and pharmacotherapy.
• To highlight the role of primary care clinicians in managing depression.

Main Methods:

• Literature review of evidence supporting depression screening.
• Analysis of first-line treatment efficacy for depression.
• Discussion of selective serotonin reuptake inhibitors (SSRIs) as preferred pharmacotherapy.

Main Results:

• Psychotherapy and pharmacotherapy demonstrate similar efficacy in reducing depressive symptoms.
• Selective serotonin reuptake inhibitors (SSRIs) are effective outpatient antidepressants, superior to placebo.
• SSRIs are generally safe across various patient groups, including pregnant, breastfeeding, and geriatric individuals, but require careful selection.

Conclusions:

• Primary care plays a vital role in the individualized, evidence-based management of depression.
• Routine screening and appropriate treatment selection are key to improving patient outcomes.
• Clinicians must consider patient-specific factors when prescribing antidepressants like SSRIs.